Frequency of depressive symptoms in patients with leprosy in a colombian caribbean city


Authors

  • Soraya Patricia Salas Romero MsC
  • Priscila Rosa Borge Pérez
  • Yineth Elvira Herrera García
  • Carlos Alberto Guerra Guardo

DOI:

https://doi.org/10.22517/25395203.25496

Keywords:

Depression, Leprosy, Hansen's Disease

Abstract

Introduction: Leprosy affects millions of people, impairing both physical and mental health and giving rise to complications such as depressive symptoms that can impact the quality of life.

Objective: To estimate the prevalence of depressive symptoms in an association of patients and former patients with Hansen's disease in a city in the Colombian Caribbean.

Materials and methods: A descriptive study with non-probabilistic sampling was conducted among members of an association of patients and former patients with Hansen's disease in a city in the Colombian Caribbean. Depressive symptoms were assessed using the Beck Depression Inventory, and the results were compared with sociodemographic and clinical variables through bivariate analysis.

Results: Fifty-one individuals participated, with an average age of 52 years (CI 35.7-68.5), and a male predominance (57%). Thirty-nine percent of the population had completed high school, 25% were undergoing treatment at the time of the survey, and 33% had some degree of disability. Twenty-seven percent, 16%, and 2% of the population exhibited mild, moderate, and severe depression, respectively. The most frequently reported depressive symptom was fatigue (13%), followed by changes in appetite (84.2%), crying (81.6%), and sadness (79%). No statistically significant relationship was found between the presence of depressive symptoms and sociodemographic characteristics, treatment, or disability.

Conclusions: It is evident that 35% of respondents scored in the range indicative of depression on the Beck Depression Inventory. Specialized mental health management is recommended to be included in the comprehensive care of patients and former patients with Hansen's disease.

Downloads

Download data is not yet available.

References

Barba EJR. Lepra. Enfermedad milenaria aún vigente. Rev. Mex Patol Clin Med Lab. 2021; 68 (1): 18-33.

Cáceres-Durán MA. Comportamiento epidemiológico de la lepra en varios países de América Latina, 2011-2020. Rev. Panam Salud Publica. 2022;46: e14.

Instituto Nacional de Salud-Colombia. Protocolo de Vigilancia en Salud Pública de Lepra. versión 7. [Internet] 2022 [consultado 10 de enero 2023].Disponible en: https://doi.org/10.33610/infoeventos.53s.7

Rivas-Minas AM, Chantré-Cusi A, Santa-Yepes J, Hoyos-Ocampo-DM, Pacheco R, Ferro BE. Determinación de la persistencia y diagnóstico tardío de lepra en el Valle del Cauca de 2010 a 2016. Rev. Fac. Nac. Salud Pública. 2021;39(3): e343156. doi: 10.17533/udea.rfnsp.e343156

Dadun D, Peters RMH, van Brakel WH, Bunders JGF, Irwanto I, Regeer BJ. Assessing the Impact of the Twin Track Socio-Economic Intervention on Reducing Leprosy-Related Stigma in Cirebon District, Indonesia. Int J Environ Res Public Health. 2019;16(3):349.

Barrutia Barreto Israel, Danielli Rocca Juan José, Solano Guillén Ynes Eliana. Estados depresivos en pacientes con enfermedades crónicas no transmisibles. Rev Cuban Med Gen Integr. 2022; 38(1):1-19.

American Psychiatric Association. Manual diagnóstico y estadístico de los trastornos mentales DSM-5 (5a. ed.). 2014. Editorial Médica Panamericana.

Mateus JC, Varela MT, Caicedo DM, Arias NL, Jaramillo CD, Morales LC, et al. ¿Responde la Resolución 8430 de 1993 a las necesidades actuales de la ética de la investigación en salud con seres humanos en Colombia? Biomédica. 2019; 39:448-63

Guerra Figueroa SE, Gómez Romero KY. Actualización en lepra. epidemiología, fisopatología, clasificación, diagnostico y tratatamiento. Crea Ciencia [Internet]. 1 de diciembre de 2020 [citado 25 de marzo de 2024];13(1):32-43. Disponible en: https://www.lamjol.info/index.php/CREACIENCIA/article/view/10465

Singh GP. Psychosocial aspects of Hansen's disease (leprosy). Indian Dermatol Online J. 2012 ;3(3):166-70.

Birkauser, M. Depression, menopause and estrogens, is there a correlation? Maturitas.2012; 15, (1):53-8.

Vlassoff C, Khot S, Rao S. Double jeopardy: Women and leprosy in India. World Health Stat Quart Rep 2010;49:120‐6.

Bakare AT, Yusuf AJ, Habib ZG, Obembe A. Anxiety and depression: a study of people with leprosy in Sokoto, North-Western Nigeria. J Psychiatry. 2015;s1. doi: 10.4172/2378-5756.S1-004

Bhatia MS, Chandra R, Bhattacharya SN, Imran M. Psychiatric morbidity and pattern of dysfunction in patients with leprosy. Indian J Dermatol. 2006;51:23‐5.

Eldaron AH, Kamel Z, Ahmad F. A study on divorce among Saudi female leprotic patients: An experience at Ibn Sina Hospital. Lepr Rev. 2000;64:166‐9.

Botero-Jaramillo, N, Padilla-Pinzón LT, Beltrán-Serrano MA, Ossa-Trujillo RH. Tratamiento de la enfermedad de Hansen en Colombia: medicalización y control de la enfermedad a lo largo del siglo XX. Rev. Fac. Nac. Salud Pública, 2017; 35(3): 358-368.

Botero Jaramillo, N., Polo Rivas, D., & Sinuco Rueda, L.La lepra en Colombia: estigma, identidad y resistencia en los siglos XX y XXI. Revista Salud Bosque. 2015;5(1): 67–79.

Downloads

Published

2024-07-17

How to Cite

Salas Romero, S. P., Borge Pérez, P. R., Herrera García, Y. E., & Guerra Guardo, C. A. . (2024). Frequency of depressive symptoms in patients with leprosy in a colombian caribbean city. Revista Médica De Risaralda, 30(1), 29–39. https://doi.org/10.22517/25395203.25496

Issue

Section

Original Article